ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,378.70
-0.61%
S&P ASX All Technology
3,885.10
-0.05%
Brent Oil
78.58
0.31%
US Dollar vs AUD
1.59495
0.05%
Bitcoin
101,534.31
-2.03%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Schrodinger Inc (SDGR) Share Price

Schrodinger Inc

Schrodinger Inc (SDGR)

NASDAQ
24.34
3.01
(14.11%)
Closed 23 January 8:00AM
Delayed by 15 minutes
24.24
-0.10
( -0.41% )
Pre Market: 11:56PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
24.24
Bid
24.24
Offer
24.25
Volume
5,321
0.00 Day's Range 0.00
16.67 52 Week Range 33.63
Market Cap
1.766B
Previous Close
24.34
Open
-
Last Trade
1
@
24.24
Last Trade Time
23:56:09
Financial Volume
-
VWAP
-
Average Volume (3m)
782,308
Shares Outstanding
72,858,767
Dividend Yield
-
PE Ratio
43.55
Earnings Per Share (EPS)
0.56
Revenue
216.67M
Net Profit
40.72M

About Schrodinger Inc

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the... Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. Schrodinger generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.schrodinger.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Schrodinger Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SDGR. The last closing price for Schrodinger was US$24.34. Over the last year, Schrodinger shares have traded in a share price range of US$ 16.67 to US$ 33.63.

Schrodinger currently has 72,858,767 shares in issue. The market capitalisation of Schrodinger is US$1.77 billion. Schrodinger has a price to earnings ratio (PE ratio) of 43.55.

Ask ADVFN Intelligence (AI)

Schrodinger (SDGR) Options Flow Summary

SDGR Options Flow

Overall Flow

Bullish

Net Premium

143k

Calls / Puts

200.00%

Buys / Sells

200.00%

OTM / ITM

50.00%

Sweeps Ratio

0.00%

SDGR Latest News

More News

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR) today reported that on January 20, 2025, the company granted restricted stock units (RSUs) with respect to 4,840 shares of the company’s common stock to four...

24 hours ago
Business Wire

Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities

Announces Expanded Research Collaboration Agreement with Otsuka Pharmaceutical Co., Ltd. On Track to Report Initial Phase 1 Data from Three Proprietary Programs in 2025 Focus on Delivering...

13 January 2025
Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR) today reported that on December 12, 2024, the company granted restricted stock units (RSUs) with respect to 8,365 shares of the company’s common stock to six...

18 December 2024
Business Wire

Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference

Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference. The live presentation will take place...

21 November 2024
Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR) today reported that on November 14, 2024, the company granted restricted stock units (RSUs) with respect to 2,785 shares of the company’s common stock to four...

20 November 2024
Business Wire

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative

– Additional funding received from the Bill & Melinda Gates Foundation to further accelerate initiative – Schrödinger, Inc. (Nasdaq: SDGR), today announced that it is broadening and...

19 November 2024
Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

14 November 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 November 2024
Edgar (US Regulatory)

Schrödinger Reports Third Quarter 2024 Financial Results

Schrödinger to Receive $150 Million Upfront for New Multi-Target Collaboration with Novartis Third Quarter Total Revenue of $35.3 Million, Software Revenue of $31.9 Million Updates 2024 Financial...

12 November 2024
Business Wire

Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis

Schrödinger to receive $150 million upfront and eligible to receive up to approximately $2.3 billion in milestone payments plus royalties Expanded multi-year software agreement enables technology...

12 November 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
14.8224.819773429519.4225.718.625133182522.82939424CS
44.7424.307692307719.525.718.276035621.12183446CS
126.7738.752146536917.4725.717.2878230820.61838749CS
261.375.9903804110222.8725.716.6769715520.11525367CS
52-3.66-13.118279569927.933.6316.6774151822.62409083CS
156-1.88-7.1975497702926.1259.2415.8578388528.72033625CS
260-6.21-20.3940886730.4511715.8587284143.96462906CS

SDGR - Frequently Asked Questions (FAQ)

What is the current Schrodinger share price?
The current share price of Schrodinger is US$ 24.24
How many Schrodinger shares are in issue?
Schrodinger has 72,858,767 shares in issue
What is the market cap of Schrodinger?
The market capitalisation of Schrodinger is USD 1.77B
What is the 1 year trading range for Schrodinger share price?
Schrodinger has traded in the range of US$ 16.67 to US$ 33.63 during the past year
What is the PE ratio of Schrodinger?
The price to earnings ratio of Schrodinger is 43.55
What is the cash to sales ratio of Schrodinger?
The cash to sales ratio of Schrodinger is 8.18
What is the reporting currency for Schrodinger?
Schrodinger reports financial results in USD
What is the latest annual turnover for Schrodinger?
The latest annual turnover of Schrodinger is USD 216.67M
What is the latest annual profit for Schrodinger?
The latest annual profit of Schrodinger is USD 40.72M
What is the registered address of Schrodinger?
The registered address for Schrodinger is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Schrodinger website address?
The website address for Schrodinger is www.schrodinger.com
Which industry sector does Schrodinger operate in?
Schrodinger operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DGNXDiginex Ltd
 16.90
(125.33%)
1.62M
FSEAFirst Seacoast Bancorp Inc
US$ 15.90
(59.00%)
7
BKHABlack Hawk Acquisition Corporation
US$ 16.55
(58.98%)
9
BBGIBeasley Broadcast Group Inc
US$ 13.31
(58.45%)
14
CRWSCrown Crafts Inc
US$ 6.99
(56.03%)
1
VIRCVirco Manufacturing Company
US$ 6.01
(-45.86%)
70
CPBICentral Plains Bancshares Inc
US$ 10.01
(-31.67%)
8
TSBKTimberland Bancorp Inc
US$ 21.01
(-27.63%)
15
XNCRXencor Inc
US$ 15.01
(-27.38%)
16
UBFOUnited Security Bancshares
US$ 7.21
(-27.25%)
15
HEPAHepion Pharmaceuticals Inc
US$ 0.183
(35.56%)
37.86M
QNRXQuoin Pharmaceuticals Ltd
US$ 0.6869
(16.50%)
28.49M
KOPNKopin Corporation
US$ 1.765
(20.07%)
20.65M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.3303
(3.54%)
8.64M
ASSTAsset Entities Inc
US$ 1.29
(-5.15%)
8M

SDGR Discussion

View Posts
jsc52033 jsc52033 2 months ago
If Biill Gates thinks its got potential it a risk I can take
👍️0
lambchops lambchops 3 months ago
Yep, it just seems like SDGR isn't getting much love. But nothing has changed as they move towards their goals. I look at it as aa time to continue to accumulate shares. One of these days SDGR will see a big jump.

Look at CERS.

All the best! stay in contact.

LC

SDGR
👍️0
north40000 north40000 3 months ago
Not much to say, currently. SDGR shares have been in a rather steady decline since I purchased a few in May 2023. I am curious where/how the company is aiding discovery of new molecules for potential use in healthcare sector, cf. the recent Nobel Prize awards. Is this turnaround time? How proficient has the company been in its AI-aided experiments?

I have concentrated more on NVDA, IONQ, JNJ, PFE, MRK, GILD, HALO, CPRX, VCEL, WGS whose market valuations seem headed higher in our portfolios.
👍️0
lambchops lambchops 6 months ago
Anybody interested on posting on this one?

LC

👍️0
scotsand scotsand 1 year ago
This needs to turn around soon. So oversold.
👍️0
scotsand scotsand 2 years ago
Beast mode
👍️0
scotsand scotsand 2 years ago
Love this ticker
👍️0
scotsand scotsand 2 years ago
Up 20%. Guess was right… adding.
👍️0
scotsand scotsand 2 years ago
Now is the time to add.
👍️0
Porterhouse10 Porterhouse10 3 years ago
Cathy Woods adding
👍️0
nowwhat2 nowwhat2 3 years ago



👍️0
adtime adtime 3 years ago
This was a fun move hope someone followed ;) 8% at peak today ftw
👍️0
adtime adtime 3 years ago
Nice set up if gets into 60
👍️0
ernie44 ernie44 4 years ago
M and A -------------------------
merger looming---microsoft
👍️0
Bucketh3ad Bucketh3ad 4 years ago
Smh
👍️0
chrispy2468 chrispy2468 5 years ago
Any insight to this upward move after hours?
👍️0
canadiansalmongal canadiansalmongal 5 years ago
Very Solid company with HUGE money supporting it...Long term Hold this is a golden ticket going forward $100 PT this time next year!
👍️0
chrispy2468 chrispy2468 5 years ago
Little action AH
👍️0
RodgeDodger RodgeDodger 5 years ago
Still running
👍️0
crudeoil24 crudeoil24 5 years ago
I am not holding shares. It may run some more, plus not everyone is familiar with Citron the beast! > LOL.
👍️0
realfast95 realfast95 5 years ago
yea he exaggerates his long ideas. TLRY,RVLV come to mind
👍️0
crudeoil24 crudeoil24 5 years ago
Citron > will they be shorting tomorrow? Playing off the TSLA hype!

👍️0
chrispy2468 chrispy2468 5 years ago
Bullish
👍️0
TheFinalCD TheFinalCD 5 years ago
https://citronresearch.com/schrodinger-sdgr-taking-drug-discovery-to-the-space-age/
👍️0
realfast95 realfast95 5 years ago
Citron pump

https://twitter.com/CitronResearch/status/1230538195726503942

Citron Research
@CitronResearch
$SDGR the most important IPO past 5 years. Taking drug discovery to "space age". The parallels to an early stage $TSLA are too obvious to ignore. Don't take Citron's word, look at the majority shareholders AI molecular simulation is real disruption. TGT- $80

👍️0
RodgeDodger RodgeDodger 5 years ago
Still running
👍️0
crudeoil24 crudeoil24 5 years ago
Schrodinger Shares Surge 55% After IPO Priced Above High End of Range >SDGR
12:39 pm ET February 6, 2020 (Dow Jones) Print
By Colin Kellaher

Shares of Schrodinger Inc. (SDGR) jumped more than 55% in their trading debut Thursday after the drug discovery software company's upsized initial public offering of 11.9 million shares was priced at $17 apiece, above the expected range.

Schrodinger shares recently were trading at $26.54, up about 56%, after opening at $26.

The New York company, whose investors include D.E. Shaw and the Bill & Melinda Gates Foundation, previously said it planned to sell 10 million shares at $14 to $16 each in the IPO.

The company has granted the underwriters an option to buy up to 1.78 million additional shares.
👍️0
crudeoil24 crudeoil24 5 years ago
Schrodinger Inc is headquartered in New York City, New York, United States and is a software publisher. The company's key areas of interest are Computational Chemistry Software, Molecular Modeling, Dockings, Homology Modeling, Cheminformatics, Pharmacophore Modeling, Qsars, Computational Biology, Computer Chemistry, Quantum Chemistry, Software For Chemistry. The company was founded in 1995.

👍️0

Your Recent History

NASDAQ
SDGR
Schrodinger
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads